Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bavarian Nordic A/S
BV3Current price
22.62 EUR
-2.38 EUR (-9.52%)
Last closed
27.7 EUR
Company
–
ISIN
DK0015998017
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
2 199 275 681 EUR
Yield for 12 month
+14.18 %
1Y
3Y
5Y
10Y
15Y
BV3
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase III clinical trial for the treatment of SARS-CoV-2. The company has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Canada, France, Germany, Spain, Australia, Switzerland, Sweden, Chile, Taiwan, the United Kingdom, Hong Kong, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark. Address: Philip Heymans Alle 3, Hellerup, Denmark, 2900
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
54.2 EURP/E ratio
22.8017Dividend Yield
–Current Year
+956 982 832 EUR
Last Year
+426 948 406 EUR
Current Quarter
+193 433 072 EUR
Last Quarter
+112 668 666 EUR
Current Year
+623 736 042 EUR
Last Year
+230 529 616 EUR
Current Quarter
+97 556 870 EUR
Last Quarter
+35 940 685 EUR
Key Figures BV3
1 year
3 years
5 years
10 years
EBITDA
1 976 485 248 EUR
Operating Margin TTM
PE Ratio
22.8017
Return On Assets TTM
5.99 %
PEG Ratio
–
Return On Equity TTM
7.03 %
Wall Street Target Price
54.2 EUR
Revenue TTM
6 148 086 433 EUR
Book Value
133.31 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-28.1 %
Dividend Yield
–
Gross Profit TTM
1 719 569 879 EUR
Earnings per share
1.22 EUR
Diluted Eps TTM
1.22 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-53.5 %
Profit Margin
11.63 %
Dividend Analytics BV3
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BV3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BV3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
22.8017
Forward PE
4.948
Enterprise Value Revenue
2.3205
Price Sales TTM
0.3577
Enterprise Value EBITDA
9.9755
Price Book MRQ
1.5485
Financials BV3
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BV3
For 52 weeks
18.66 EUR
43.16 EUR
50 Day MA
30.47 EUR
Shares Short Prior Month
–
200 Day MA
25.42 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart